Amount Raised
$1 Million
Round Type
seed
Description
Rubix LS, a minority-led life science research firm focusing on solutions to support minorities within clinical trials, announced today that it had completed a $1.25 million Seed round of financing. With the financing round being secured by many private and angel investors, the investment capitalizes on the further momentum for the virtual clinical trial platform, StarSense, and the intimate engagement with minority patients for continued care for early-stage research. Harmonizing on the events during the COVID-19 pandemic, StarSense made further advances globally to support underrepresented groups to be included in infectious disease clinical trial research programs. Furthering from inclusion, the platform has led to a 38% increase in therapeutic benefits for therapies that were otherwise unknown to support and treat specific conditions.